| Dr Renuka Sothinathan, MD | |
|
3930 Walnut Street, Suite 101, Fairfax, VA 22030-4738 | |
| (703) 246-9246 | |
| (703) 246-9257 |
| Full Name | Dr Renuka Sothinathan |
|---|---|
| Gender | Female |
| Speciality | Nephrology |
| Experience | 32 Years |
| Location | 3930 Walnut Street, Fairfax, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225124779 | NPI | - | NPPES |
| 010084504 | Medicaid | VA | |
| 47430005 | Other | CAREFIRST | |
| 005882842 | Medicaid | VA | |
| 010184886 | Medicaid | VA | |
| 010084512 | Medicaid | VA | |
| 010084539 | Medicaid | VA | |
| 010084423 | Medicaid | VA | |
| 010084474 | Medicaid | VA | |
| 010084628 | Medicaid | VA | |
| 010084598 | Medicaid | VA | |
| 010084610 | Medicaid | VA | |
| 010084814 | Medicaid | VA | |
| 2319484 | Other | UNITED HEALTHCARE | |
| 010084482 | Medicaid | VA | |
| 010084440 | Medicaid | VA | |
| 010084679 | Medicaid | VA | |
| 010084792 | Medicaid | VA | |
| 4530480 | Other | CIGNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 0101232750 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Renal Carepartners - Arlington/alexandria | Arlington, VA | Dialysis facility |
| Renal Carepartners - Fairfax | Fairfax, VA | Dialysis facility |
| Davita - Arlington | Arlington, VA | Dialysis facility |
| Virginia Hospital Center | Arlington, VA | Hospital |
| Inova Alexandria Hospital | Alexandria, VA | Hospital |
| Inova Fairfax Hospital | Falls church, VA | Hospital |
| Inova Fair Oaks Hospital | Fairfax, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Virginia Nephrology Group Llp | 2062471857 | 14 |
| Virginia Nephrology Group Llp | 2062471857 | 14 |
News Archive
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has approved QNASL Nasal Aerosol, a new, "dry" nasal aerosol corticosteroid that treats seasonal nasal and year-round nasal allergy symptoms in adults and adolescents 12 years of age and older.
University of Michigan researchers have found that patients with severe cases of the H1N1 virus are at risk for developing severe complications, including pulmonary emboli, according to a study published today in the American Journal of Roentgenology.
For patients with the most common form of hepatitis C being treated for the first time, the addition of an investigational hepatitis C-specific protease inhibitor called telaprevir to the current standard therapy markedly improved their sustained viral response (SVR or viral cure) rate.
A new study from University of California, Berkeley, researchers demonstrates that adult stem cells can reshape our organs in response to changes in the body and the environment, a finding that could have implications for diabetes and obesity.
Recent research suggests vitamin D may be able to stop or prevent cancer. Now, a new study finds an enzyme that plays a role in metabolizing vitamin D can predict lung cancer survival.
› Verified 7 days ago
| Entity Name | Virginia Nephrology Group Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013001601 PECOS PAC ID: 2062471857 Enrollment ID: O20041007000398 |
News Archive
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has approved QNASL Nasal Aerosol, a new, "dry" nasal aerosol corticosteroid that treats seasonal nasal and year-round nasal allergy symptoms in adults and adolescents 12 years of age and older.
University of Michigan researchers have found that patients with severe cases of the H1N1 virus are at risk for developing severe complications, including pulmonary emboli, according to a study published today in the American Journal of Roentgenology.
For patients with the most common form of hepatitis C being treated for the first time, the addition of an investigational hepatitis C-specific protease inhibitor called telaprevir to the current standard therapy markedly improved their sustained viral response (SVR or viral cure) rate.
A new study from University of California, Berkeley, researchers demonstrates that adult stem cells can reshape our organs in response to changes in the body and the environment, a finding that could have implications for diabetes and obesity.
Recent research suggests vitamin D may be able to stop or prevent cancer. Now, a new study finds an enzyme that plays a role in metabolizing vitamin D can predict lung cancer survival.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Renuka Sothinathan, MD 3930 Walnut Street, Suite 101, Fairfax, VA 22030-4738 Ph: (703) 246-9246 | Dr Renuka Sothinathan, MD 3930 Walnut Street, Suite 101, Fairfax, VA 22030-4738 Ph: (703) 246-9246 |
News Archive
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has approved QNASL Nasal Aerosol, a new, "dry" nasal aerosol corticosteroid that treats seasonal nasal and year-round nasal allergy symptoms in adults and adolescents 12 years of age and older.
University of Michigan researchers have found that patients with severe cases of the H1N1 virus are at risk for developing severe complications, including pulmonary emboli, according to a study published today in the American Journal of Roentgenology.
For patients with the most common form of hepatitis C being treated for the first time, the addition of an investigational hepatitis C-specific protease inhibitor called telaprevir to the current standard therapy markedly improved their sustained viral response (SVR or viral cure) rate.
A new study from University of California, Berkeley, researchers demonstrates that adult stem cells can reshape our organs in response to changes in the body and the environment, a finding that could have implications for diabetes and obesity.
Recent research suggests vitamin D may be able to stop or prevent cancer. Now, a new study finds an enzyme that plays a role in metabolizing vitamin D can predict lung cancer survival.
› Verified 7 days ago
Shivangi Vachhani, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 3700 Joseph Siewick Dr Ste 408a, Fairfax, VA 22033 Phone: 877-511-4625 Fax: 703-204-9006 | |
Dr. Raymund S Cuevo, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 8081 Innovation Park Dr, Fairfax, VA 22031 Phone: 571-472-4724 Fax: 571-472-0241 | |
Dr. Michael Maitland, M.D., PH.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 8081 Innovation Park Dr, Fairfax, VA 22031 Phone: 571-472-4724 Fax: 571-472-1601 | |
Dr. Paul G. Rochmis, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 3027 Javier Rd, Suite 2, Fairfax, VA 22031 Phone: 703-573-2220 Fax: 703-573-7767 | |
Aswani Kumar Suthrave, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3600 Joseph Siewick Dr, Fairfax, VA 22033 Phone: 703-391-3600 | |
Nader H Balba, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3028 Javier Rd Ste 500, Fairfax, VA 22031 Phone: 703-698-8960 Fax: 571-494-5794 | |
Rona Harthill Earle, Nephrology Medicare: Not Enrolled in Medicare Practice Location: 3020 Hamaker Ct Ste B102, Fairfax, VA 22031 Phone: 703-573-4072 Fax: 703-572-2153 |